Search

everythinglearnresearchcommunity

for

Search:↓

Breathing in newborn rats is affected differently by hormones based on their sex.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

A woman's hair loss improved with treatment after a COVID-19 infection.

Low-level laser therapy may help uninfected cells but has different effects on coronavirus-infected cells.

Finasteride may help reduce COVID-19 infection by altering a key gene.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

A woman with Castleman's disease died from respiratory failure due to bronchiolitis obliterans.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

During the COVID-19 pandemic in China, skin conditions like eczema and warts increased among children, while respiratory-transmitted skin infections decreased, partly due to mask-wearing.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

COVID-19 may cause temporary hair loss in some people.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

A patient with Myotonic dystrophy type 1 had multiple tongue hemangiomas and was sensitive to anesthesia.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

A protein called MPZL3 in mitochondria slows down hair growth and could be a target for treating hair growth disorders.

Myoepithelial cells can repair airways after severe injury.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.